These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29570967)

  • 1. Successful Treatment of Catatonia with Methylphenidate in a 25-Year-Old Patient With Schizophrenia.
    Zeshan M; Majeed MH; Hanif A
    Prim Care Companion CNS Disord; 2018 Mar; 20(2):. PubMed ID: 29570967
    [No Abstract]   [Full Text] [Related]  

  • 2. A Rare Presentation of Catatonia due to Primary Adrenal Insufficiency.
    Puzanov M; Davis H; Holmes EG
    Psychosomatics; 2019; 60(6):630-633. PubMed ID: 31000141
    [No Abstract]   [Full Text] [Related]  

  • 3. The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls.
    Koreen AR; Lieberman JA; Alvir J; Chakos M
    Neuropsychopharmacology; 1997 Jan; 16(1):61-8. PubMed ID: 8981389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic catatonia with long-term treatment: a case report.
    Chen RA; Huang TL
    BMC Psychiatry; 2017 Sep; 17(1):337. PubMed ID: 28962597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of catatonia with olanzapine and amantadine.
    Babington PW; Spiegel DR
    Psychosomatics; 2007; 48(6):534-6. PubMed ID: 18071103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.
    Lin CC; Huang TL
    Compr Psychiatry; 2013 Nov; 54(8):1210-4. PubMed ID: 23856388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of methylphenidate on eating in obese men.
    Leddy JJ; Epstein LH; Jaroni JL; Roemmich JN; Paluch RA; Goldfield GS; Lerman C
    Obes Res; 2004 Feb; 12(2):224-32. PubMed ID: 14981214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catatonia].
    Bruijn DJ; Blom JD
    Ned Tijdschr Geneeskd; 2010; 154():A2284. PubMed ID: 20977815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY; Yang PS; Huang TL
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder.
    de Lucena DF; Pinto JP; Hallak JE; Crippa JA; Gama CS
    J Clin Psychopharmacol; 2012 Aug; 32(4):569-72. PubMed ID: 22760350
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine Modulates the Efficiency of Sensory Evidence Accumulation During Perceptual Decision Making.
    Beste C; Adelhöfer N; Gohil K; Passow S; Roessner V; Li SC
    Int J Neuropsychopharmacol; 2018 Jul; 21(7):649-655. PubMed ID: 29618012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice.
    Issy AC; Salum C; Del Bel EA
    Behav Brain Res; 2009 Dec; 205(2):475-81. PubMed ID: 19665495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of catatonia with methylphenidate in an elderly patient with depression.
    Prowler ML; Weiss D; Caroff SN
    Psychosomatics; 2010; 51(1):74-6. PubMed ID: 20118444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of treatment-resistant schizophrenia in a 10-year-catatonic patient by augmentation of selective serotonin reuptake inhibitors: a case report.
    Chen MJ; Huang SS; Juang KD; Chan CH
    Medicine (Baltimore); 2015 May; 94(17):e769. PubMed ID: 25929916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between sensitivity to methylphenidate and predisposition to catatonia in rats].
    Kolpakov VG; Barykina NN; Chepkasov IL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(5):1054-62. PubMed ID: 7198345
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of catatonia with amantadine.
    Hervey WM; Stewart JT; Catalano G
    Clin Neuropharmacol; 2012; 35(2):86-7. PubMed ID: 22356926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case Report ; Malignant catatonia in a patient with schizophrenia.].
    Nakajima S; Aoshima T; Kuranobu T; Motohashi I; Katayama J; Ueda T; Kamiya T
    Nihon Naika Gakkai Zasshi; 2016 May; 105(5):887-892. PubMed ID: 29182842
    [No Abstract]   [Full Text] [Related]  

  • 20. DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.
    Ding K; Yang J; Reynolds GP; Chen B; Shao J; Liu R; Qian Q; Liu H; Yang R; Wen J; Kang C
    World J Biol Psychiatry; 2017 Jun; 18(4):291-299. PubMed ID: 27676100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.